Introducing Primeview
As an innovation leader in advanced display solutions, PRIMEVIEW takes pride in combining state of the art design with 24/7 military level reliability. Our Interactive tables and monitors offer an unparalleled multi-user experience and collaboration tool across mulitple verticals including Command and Control, Corporate, Education, Retail, Museums, Broadcast, Health Care, Hospitality and Gaming and more. PRIMEVIEW has made significant investments to achieve our innovation goals in the interactive display space.
Our Vision - Adavanced Solutions you can count on
Primeview was launched in 1997 as a company specializing in Visual Solutions, with a focus on the corporate market. Primeview designs produces and delivers cutting-edge visual display technology for a wide variety of markets. Our production lines are tailored to meet the stringent needs of our clients in a reliable and continuous manner. Primeview’s products went through vigorous and exhaustive testing with Independent Safety & Standards Organizations. Our products attained QA Double Control and Intensive Lab Certifications due to the high demand of our customers. Some of our products have attained MIL spec, RoHS, as well as medical certifications.
Interactive Collobrative Technology
Primeview Video Walls combine the latest LCD and plasma design with the functionality of traditional video walls. Our seamless Plasmas have an anti-reflective surface and combined with incredible brightness and contrast are guaranteed to capture an audience's attention and present any content beautifully. Our line of super narrow LED LCD displays screens are designed to be installed and operate efficiently. Primeview works closely with many hardware manufactures globally to ensure that connectivity, video processing, and signage software all work seamlessly. In 2012, Primeview began offering turnkey interactive video walls with articulated mounting and interactivity built in. With more versatility and an array of brightness options, our video walls are a step into the future.
Tired of your fans’ social content going to waste?
Whether you are a sports team, an artist, a fashion brand or a tech company, If you are hosting events, your fans are posting content about you...
Why can’t you use this content to propel your brand?
Pico is the only tool that is able to boost your brand's awareness and fan engagement using the content fans are already posting.
Our hard working bees will swarm over this content, give you detailed insights about your fans, and most importantly - create HUGE BUZZ!
#StopSocialWaste now!
Cyberfy is a revolutionary cybersecurity solution conceived and developed in Israel in 2013. Cyberfy surpasses the most stringent governmental and corporate security standards using multi-layered (5 Factor) biometric, pattern-recognition authentication that stops cyber-attacks before they begins using secure, non-tangible, biometric login credential that authenticates the conducting parties and not user names and passwords.
Producing Fuel/Chemicals from CO2 Using Renewable Energy Sources
NewCO2Fuels’ (NCF) revolutionary product provides a solution to today’s climate change by directly addressing its main cause, namely CO2 emissions.
NCF’s innovative product enables large industrial plants to comply with environmental constrains and regulatory objectives and reduce their CO2 emission by providing them with an efficient, revenue generating and clean solution to convert these emissions into valuable fuels and chemicals.
The system uses renewable electricity or recovered high temperature heat from industrial plants to drive its process, hence creating a 100% self-sufficient, revenues bearing and environmental friendly system.
Accellix, our fully automated tabletop diagnostic device with single-use cartridges, expands access to complex flow cytometry capabilities to any medical practitioner on a 24/7 basis, providing clinical results in less than 30 minutes.
LeukoDx is launching is first product, Accellix CD64, a well-characterized marker of neutrophil activation and an early and sensitive marker of host immune response to severe infection and sepsis, in the EU in 2016. The detection of infection and elevated neutrophil activation using the Accellix CD64 will help identify patients who are at high risk of developing sepsis. LeukoDx has identified a pipeline of several key high-value tests for its Accellix platform, including HLA-DR, a marker for immune depression, a leading cause of death in sepsis, which will be available in the EU in the 2nd quarter of 2016.
EyeYon Medical is a startup company that specializes in development of medical ophthalmic devices and has promising, exclusive technologies that have proven the feasibility of a solution to an acute problem in the ophthalmic world.
EyeYon has developed two main technologies:
The Hyper CL,hyperosmotic Contact Lens, is a unique soft contact lens that creates a cavity above the center of the cornea. This cavity can store hypertonic drops for a long duration and by doing so extracts fluids by osmosis from the cornea. The Hyper CL has shown impressive capabilities for the relief of corneal edema in clinical trials. The unique design of the lens has been found to be beneficial for a variety of indications that are now being tested, among others corneal edema and dry eye syndrome. The Hyper CL is CE approved, awaiting 510k approval and at a commercialization stage.
DSPEK, Descemet’s Stripping Pseudo Endothelial Keratoplasty, offers a solution by an implant in the form of a silicon film attached to the posterior corneal surface, thereby resolving the “root” of the problem. The DSPEK has proven feasibility in preclinical trials.